ArticleCardiovascular diabetology2023

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy.

Katherine G Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.